Abstracts tagged "Sarcoidosis and ultrasound"

Abstract Number: 1214 • 2018 ACR/ARHP Annual Meeting
Comparison of Ultrasound Features of Major Salivary Glands in Sarcoidosis, Amyloidosis, and Sjögren’s Syndrome
Shing Law¹, Praveen Govender², S. Reza Jafarzadeh³, Xianbang Sun⁴, Vaishali Sanchorawala⁵ and Eugene Y. Kissin⁶, ¹Rheumatology, Boston Medical Center, Boston, MA, ²The Pulmonary Center, Sarcoidosis Center, Boston University School of Medicine, Boston, MA, ³Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ⁴Boston University, Boston, MA, ⁵Division of Hematology and Oncology, Boston University School of Medicine, Boston, MA, ⁶Rheumatology, Boston University, Boston, MA
Background/Purpose: Salivary gland enlargement occurs in conditions such as Sjögren’s syndrome (SS), sarcoidosis (SAR), and AL amyloidosis (AL). Salivary gland ultrasound (US) has been shown…
Abstract Number: 1047 • 2012 ACR/ARHP Annual Meeting
Evaluation of Ankle Swelling Due to Löfgren´s Syndrome: A Pilot Study Using B –mode and Power Doppler Ultrasonography
Emmanuelle LeBras¹, Sandra Balser¹, Valentin S. Schäfer¹, Boris P. Ehrenstein², Patrick Hoffstetter³, Martina Müller⁴, Martin Fleck² and Wolfgang Hartung², ¹Rheumatology & Clinical Immunology, Asklepios Klinikum Bad Abbach, Bad Abbach, Germany, ²Rheumatology & Clinical Immunology, Asklepios Clinic Bad Abbach, Bad Abbach, Germany, ³Radiology, Asklepios Klinikum Bad Abbach, Bad Abbach, Germany, ⁴Clinic for Internal Medicine I, University Clinic Regensburg, Regensburg
Background/Purpose: Patients suffering from acute sarcoidosis frequently present with bilateral painfull swelling of the ankles, establishing ankle arthritis as a hallmark of Löfgren's syndrome. Standardized…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].